ReviewBMC cancer2018

Long-term efficacy of crizotinib in a metastatic papillary renal carcinoma with MET amplification: a case report and literature review.

Philippe Rochigneux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.